Bal Pharma Limited (BALPHARMA.BO)
INR 120.0
(-0.87%)
INR 120.0
(-0.87%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 878.11 Million INR | -10.4% |
| 2022 | 980.05 Million INR | 31.73% |
| 2021 | 743.95 Million INR | 23.2% |
| 2020 | 603.85 Million INR | -10.82% |
| 2019 | 677.11 Million INR | -2.92% |
| 2018 | 697.51 Million INR | 4.9% |
| 2017 | 664.93 Million INR | 21.49% |
| 2016 | 547.3 Million INR | 31.08% |
| 2015 | 417.54 Million INR | 16.58% |
| 2014 | 358.15 Million INR | 12.93% |
| 2013 | 317.14 Million INR | -5.86% |
| 2012 | 336.87 Million INR | 0.08% |
| 2011 | 336.59 Million INR | 4.49% |
| 2010 | 322.14 Million INR | 12.55% |
| 2009 | 286.22 Million INR | 19.83% |
| 2008 | 238.86 Million INR | -6.14% |
| 2007 | 254.5 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q4 | 878.11 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 1.05 Billion INR | 0.0% |
| 2023 FY | 878.11 Million INR | -10.4% |
| 2022 Q4 | 980.05 Million INR | 0.0% |
| 2022 FY | 980.05 Million INR | 31.73% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 862.48 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2021 Q2 | 614 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 743.95 Million INR | 23.2% |
| 2021 Q4 | 743.95 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 Q2 | 565.48 Million INR | 0.0% |
| 2020 FY | 603.85 Million INR | -10.82% |
| 2020 Q4 | 603.85 Million INR | 0.0% |
| 2019 FY | 677.11 Million INR | -2.92% |
| 2019 Q2 | 661.16 Million INR | 0.0% |
| 2019 Q4 | 677.11 Million INR | 0.0% |
| 2018 Q4 | 697.51 Million INR | 0.0% |
| 2018 FY | 697.51 Million INR | 4.9% |
| 2017 Q4 | 664.93 Million INR | 0.0% |
| 2017 FY | 664.93 Million INR | 21.49% |
| 2016 Q2 | 432.68 Million INR | 0.0% |
| 2016 Q4 | 547.3 Million INR | 0.0% |
| 2016 FY | 547.3 Million INR | 31.08% |
| 2015 Q2 | 374.38 Million INR | 0.0% |
| 2015 Q4 | 417.54 Million INR | 0.0% |
| 2015 FY | 417.54 Million INR | 16.58% |
| 2014 FY | 358.15 Million INR | 12.93% |
| 2014 Q2 | 315.44 Million INR | 0.0% |
| 2014 Q4 | 358.15 Million INR | 0.0% |
| 2013 Q2 | 340.48 Million INR | 0.0% |
| 2013 FY | 317.14 Million INR | -5.86% |
| 2013 Q4 | 317.14 Million INR | 0.0% |
| 2012 Q2 | 334.72 Million INR | 0.0% |
| 2012 Q4 | 336.87 Million INR | 0.0% |
| 2012 FY | 336.87 Million INR | 0.08% |
| 2011 Q4 | 336.59 Million INR | 0.0% |
| 2011 FY | 336.59 Million INR | 4.49% |
| 2010 FY | 322.14 Million INR | 12.55% |
| 2009 FY | 286.22 Million INR | 19.83% |
| 2008 FY | 238.86 Million INR | -6.14% |
| 2007 FY | 254.5 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Ajanta Pharma Limited | 8.28 Billion INR | 89.399% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -203.796% |
| Sigachi Industries Limited | 707.2 Million INR | -24.166% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -739.682% |
| Medico Remedies Limited | 163.37 Million INR | -437.494% |
| Lasa Supergenerics Limited | 190.43 Million INR | -361.112% |
| Venus Remedies Limited | 1.21 Billion INR | 27.84% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Alpa Laboratories Limited | 136.65 Million INR | -542.587% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 87.617% |
| Shilpa Medicare Limited | 3.44 Billion INR | 74.542% |
| Aarti Drugs Limited | 4.85 Billion INR | 81.928% |
| Lupin Limited | 49.53 Billion INR | 98.227% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 99.105% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 97.449% |
| Windlas Biotech Limited | 621.89 Million INR | -41.201% |
| Suven Life Sciences Limited | 7.08 Million INR | -12293.987% |
| Eris Lifesciences Limited | 1.89 Billion INR | 53.547% |
| Valiant Laboratories Limited | 100.15 Million INR | -776.764% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 82.525% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 75.588% |
| Ipca Laboratories Limited | 24.71 Billion INR | 96.447% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | 25.865% |
| Achyut Healthcare Limited | 568 Thousand INR | -154497.535% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 99.11% |
| Bajaj HealthCare Limited | 1.44 Billion INR | 39.036% |
| RPG Life Sciences Limited | 1.01 Billion INR | 13.058% |
| Mankind Pharma Limited | 15.53 Billion INR | 94.347% |
| Laurus Labs Limited | 18.45 Billion INR | 95.242% |
| Piramal Pharma Limited | 21.75 Billion INR | 95.964% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -316.533% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 96.147% |
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 94.657% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 96.506% |
| Unichem Laboratories Limited | 7.04 Billion INR | 87.539% |
| Sequent Scientific Limited | 3.46 Billion INR | 74.638% |
| Novartis India Limited | 448.6 Million INR | -95.745% |
| Wanbury Limited | 360.23 Million INR | -143.763% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 62.019% |
| Wockhardt Limited | 6.4 Billion INR | 86.279% |
| Themis Medicare Limited | 705.74 Million INR | -24.424% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -485.526% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 93.191% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 86.827% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 98.618% |
| Divi's Laboratories Limited | 31.84 Billion INR | 97.242% |
| NATCO Pharma Limited | 7 Billion INR | 87.464% |
| Gufic Biosciences Limited | 2 Billion INR | 56.2% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 79.331% |
| Ind-Swift Limited | 640.91 Million INR | -37.009% |
| Procter & Gamble Health Limited | 1.09 Billion INR | 19.52% |
| FDC Limited | 3.88 Billion INR | 77.42% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -796.364% |
| Granules India Limited | 13 Billion INR | 93.248% |
| Medicamen Biotech Limited | 593.75 Million INR | -47.892% |
| Alkem Laboratories Limited | 26.61 Billion INR | 96.7% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | 61.466% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -3343.989% |
| Brooks Laboratories Limited | 96.1 Million INR | -813.674% |
| Megasoft Limited | - INR | -Infinity% |
| ZIM Laboratories Limited | 812.62 Million INR | -8.058% |
| Strides Pharma Science Limited | 11.26 Billion INR | 92.203% |
| Neuland Laboratories Limited | 3.5 Billion INR | 74.941% |
| Morepen Laboratories Limited | 2.48 Billion INR | 64.677% |
| Hikal Limited | 3.03 Billion INR | 71.088% |
| Indoco Remedies Limited | 3.53 Billion INR | 75.128% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 86.341% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -2101.891% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | 28.978% |
| Hester Biosciences Limited | 755.81 Million INR | -16.182% |